Assyro AI

Orange Book product · Generic (ANDA)

NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)

NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

Generic (ANDA)ANDA 209225TE ABRX AUROBINDO PHARMA

At a glance

Mar 30, 2023

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 30, 2023

    3 yr 3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

Strength

75MG;25MG

Dosage form

CAPSULE

Route

ORAL

TE code

AB

Application

ANDA 209225

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.